{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:15:05Z","timestamp":1772136905011,"version":"3.50.1"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.prp.2022.153982","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T02:29:44Z","timestamp":1655260184000},"page":"153982","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Association between microRNAs and chemoresistance in pancreatic cancer: Current knowledge, new insights, and forthcoming perspectives"],"prefix":"10.1016","volume":"236","author":[{"given":"Negin","family":"Rahnama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadsaleh","family":"Jahangir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira","family":"Alesaeid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Saeed","family":"kahrizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Adili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebar N.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramin","family":"Aslaminabad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morteza","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Mert","family":"\u00d6zg\u00f6n\u00fcl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2022.153982_bib1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.21147\/j.issn.1000-9604.2020.06.04","article-title":"Current epidemiology of pancreatic cancer: challenges and opportunities","volume":"32","author":"Luo","year":"2020","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.prp.2022.153982_bib2","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA: Cancer J. Clin."},{"key":"10.1016\/j.prp.2022.153982_bib3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.addr.2014.09.006","article-title":"miRNAs in pancreatic cancer: therapeutic potential, delivery challenges and strategies","volume":"81","author":"Chitkara","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.prp.2022.153982_bib4","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.3892\/ol.2017.5777","article-title":"Chemoresistance in pancreatic cancer: Emerging concepts","volume":"13","author":"Gnanamony","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2022.153982_bib5","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1002\/cncr.30927","article-title":"Second\u2010line treatment in patients with pancreatic ductal adenocarcinoma: A meta\u2010analysis","volume":"123","author":"Sonbol","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2022.153982_bib6","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.21981.1","article-title":"Recent advances in the treatment of pancreatic cancer","volume":"9","author":"Roth","year":"2020","journal-title":"F1000Research"},{"key":"10.1016\/j.prp.2022.153982_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000267","article-title":"Preoperative\/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages","volume":"7","author":"Gillen","year":"2010","journal-title":"PLoS Med."},{"key":"10.1016\/j.prp.2022.153982_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/medicina54030048","article-title":"Chemotherapy in pancreatic cancer: A systematic review","volume":"54","author":"Hajatdoost","year":"2018","journal-title":"Medicina"},{"key":"10.1016\/j.prp.2022.153982_bib9","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/sj.bjc.6605256","article-title":"A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer","volume":"101","author":"Ueno","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2022.153982_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.gde.2017.10.001","article-title":"The role of alternative splicing in cancer drug resistance","volume":"48","author":"Siegfried","year":"2018","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.prp.2022.153982_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0360-3016(03)00451-6","article-title":"Adjuvant therapy for pancreatic adenocarcinoma: what have we learned since 1985?","volume":"56","author":"Abrams","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.prp.2022.153982_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/cancers9090122","article-title":"EMT and treatment resistance in pancreatic cancer","volume":"9","author":"Gaianigo","year":"2017","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2022.153982_bib13","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3390\/cancers13040749","article-title":"Extracellular vesicles: emerging modulators of cancer drug resistance","volume":"13","author":"Fontana","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2022.153982_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5306\/wjco.v7.i1.27","article-title":"Current therapeutic strategies for advanced pancreatic cancer: a review for clinicians","volume":"7","author":"Spadi","year":"2016","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.prp.2022.153982_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7150\/ijbs.14951","article-title":"The landscape of pancreatic cancer therapeutic resistance mechanisms","volume":"12","author":"Chand","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.prp.2022.153982_bib16","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.pan.2021.01.010","article-title":"Combating pancreatic cancer chemoresistance by triggering multiple cell death pathways","volume":"21","author":"Santofimia-Casta\u00f1o","year":"2021","journal-title":"Pancreatology"},{"key":"10.1016\/j.prp.2022.153982_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/cancers9110157","article-title":"Pancreatic cancer chemoresistance to gemcitabine","volume":"9","author":"Amrutkar","year":"2017","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2022.153982_bib18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15171\/apb.2017.041","article-title":"The different mechanisms of cancer drug resistance: a brief review","volume":"7","author":"Mansoori","year":"2017","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.prp.2022.153982_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrgastro.2010.188","article-title":"Pancreatic cancer: understanding and overcoming chemoresistance","volume":"8","author":"Wang","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.prp.2022.153982_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184504","article-title":"Chemoresistance in Pancreatic Cancer","volume":"20","author":"Zeng","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2022.153982_bib21","doi-asserted-by":"crossref","first-page":"djv222","DOI":"10.1093\/jnci\/djv222","article-title":"The role of multidrug resistance efflux pumps in cancer: revisiting a JNCI publication exploring expression of the MDR1 (P-glycoprotein) gene","volume":"107","author":"Gottesman","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.prp.2022.153982_bib22","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2174\/138161282005140214165212","article-title":"ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development","volume":"20","author":"Choi","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.prp.2022.153982_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP\u2013dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2022.153982_bib24","doi-asserted-by":"crossref","unstructured":"F.J. Sharom, ABC multidrug Transp.: Struct., Funct. role chemoresistance 2008.","DOI":"10.2217\/14622416.9.1.105"},{"key":"10.1016\/j.prp.2022.153982_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrc2789","article-title":"ABC transporters in cancer: more than just drug efflux pumps","volume":"10","author":"Fletcher","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2022.153982_bib26","unstructured":"X. Wang, H. Zhang, X. Chen, Drug Resist. Combat. Drug Resist. Cancer Cancer Drug Resist. (Alhambra, Calif. ), 2, 2019, pp. 141\u2013160."},{"key":"10.1016\/j.prp.2022.153982_bib27","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/1878-0261.12322","article-title":"GRP 78\u2013mediated antioxidant response and ABC transporter activity confers chemoresistance to pancreatic cancer cells","volume":"12","author":"Dauer","year":"2018","journal-title":"Mol. Oncol."},{"issue":"2014","key":"10.1016\/j.prp.2022.153982_bib28","article-title":"ATP-binding cassette genes genotype and expression: a potential association with pancreatic cancer development and chemoresistance?","author":"Pang","year":"2014","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.prp.2022.153982_bib29","article-title":"MicroRNA-gene signaling pathways in pancreatic cancer","volume":"36","author":"Drakaki","year":"2013","journal-title":"Biomed. J."},{"key":"10.1016\/j.prp.2022.153982_bib30","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.1158\/0008-5472.CAN-09-4531","article-title":"miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer","volume":"70","author":"Yu","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2022.153982_bib31","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/gutjnl-2012-302529","article-title":"Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer","volume":"62","author":"Jacobetz","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.prp.2022.153982_bib32","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","article-title":"Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma","volume":"25","author":"Rhim","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.prp.2022.153982_bib33","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/fcp.12521","article-title":"Cancer stem cells as therapeutic targets of pancreatic cancer","volume":"34","author":"Razi","year":"2020","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.prp.2022.153982_bib34","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.2174\/0929867324666170127095832","article-title":"Targeting cancer stem cells for chemoprevention of pancreatic cancer","volume":"25","author":"Subramaniam","year":"2018","journal-title":"Curr. Med. Chem."},{"issue":"2014","key":"10.1016\/j.prp.2022.153982_bib35","article-title":"Molecular mechanisms underlying the role of microRNAs in the chemoresistance of pancreatic cancer","author":"Garajov\u00e1","year":"2014","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.prp.2022.153982_bib36","doi-asserted-by":"crossref","first-page":"v7","DOI":"10.1093\/annonc\/mdj941","article-title":"Cellular pharmacology of gemcitabine","volume":"17","author":"Mini","year":"2006","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2022.153982_bib37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3747\/co.v18i1.708","article-title":"Oxaliplatin: a review in the era of molecularly targeted therapy","volume":"18","author":"Alcindor","year":"2011","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.prp.2022.153982_bib38","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1158\/1535-7163.MCT-07-0009","article-title":"MicroRNA expression profiles for the NCI-60 cancer cell panel","author":"Blower","year":"2007","journal-title":"Mol. Cancer Therapeutics"},{"key":"10.1016\/j.prp.2022.153982_bib39","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/iub.2345","article-title":"Shotorbani, miR-143 acts as an inhibitor of migration and proliferation as well as an inducer of apoptosis in melanoma cancer cells in vitro","volume":"72","author":"Nabipoorashrafi","year":"2020","journal-title":"IUBMB Life"},{"key":"10.1016\/j.prp.2022.153982_bib40","article-title":"Dysregulation of miR-27a and SMAD2 can be a reliable indicator in the prognosis and diagnosis of CRC as well as in response to chemotherapy drugs","volume":"21","author":"Azar","year":"2020","journal-title":"Gene Rep."},{"key":"10.1016\/j.prp.2022.153982_bib41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12029-019-00356-0","article-title":"Prognostic and diagnostic values of miR-506 and SPON 1 in colorectal cancer with clinicopathological considerations","volume":"52","author":"Tamjidifar","year":"2021","journal-title":"J. Gastrointest. Cancer"},{"key":"10.1016\/j.prp.2022.153982_bib42","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2174\/138920210793175895","article-title":"MicroRNA: biogenesis, function and role in cancer","volume":"11","author":"MacFarlane","year":"2010","journal-title":"Curr. Genom."},{"key":"10.1016\/j.prp.2022.153982_bib43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.critrevonc.2011.03.010","article-title":"Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice","volume":"81","author":"Giovannetti","year":"2012","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"key":"10.1016\/j.prp.2022.153982_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107355","article-title":"miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4","volume":"92","author":"Azar","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.prp.2022.153982_bib45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12029-019-00239-4","article-title":"Evaluation of the methylation of MIR129-2 gene in gastric cancer","volume":"51","author":"Alizadeh","year":"2020","journal-title":"J. Gastrointest. Cancer"},{"key":"10.1016\/j.prp.2022.153982_bib46","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/excr.2000.4838","article-title":"Induction of apoptosis by cancer chemotherapy","volume":"256","author":"Kaufmann","year":"2000","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.prp.2022.153982_bib47","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1093\/nar\/gkn522","article-title":"miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes","volume":"36","author":"Liu","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.prp.2022.153982_bib48","article-title":"Restoration of miR-124 serves as a promising therapeutic approach in CRC by affecting CDK6 which is itself a prognostic and diagnostic factor","volume":"24","author":"Akbari","year":"2021","journal-title":"Gene Rep."},{"key":"10.1016\/j.prp.2022.153982_bib49","doi-asserted-by":"crossref","first-page":"16606","DOI":"10.1074\/jbc.M111.227611","article-title":"miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein","volume":"286","author":"Dar","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2022.153982_bib50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/18755666MTA2pNTIk0","article-title":"Heat shock proteins regulating toll-like receptors and the immune system could be a novel therapeutic target for melanoma","volume":"21","author":"Shomali","year":"2021","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.prp.2022.153982_bib51","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s12015-018-9808-y","article-title":"Cell cycle regulation of stem cells by MicroRNAs","volume":"14","author":"Mens","year":"2018","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.prp.2022.153982_bib52","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13148-018-0587-8","article-title":"The role and mechanisms of action of microRNAs in cancer drug resistance","volume":"11","author":"Si","year":"2019","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.prp.2022.153982_bib53","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1158\/1535-7163.MCT-08-1046","article-title":"MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents","volume":"8","author":"Cochrane","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.prp.2022.153982_bib54","doi-asserted-by":"crossref","first-page":"31079","DOI":"10.1074\/jbc.M806041200","article-title":"MicroRNA-221\/222 negatively regulates estrogen receptor\u03b1 and is associated with tamoxifen resistance in breast cancer","volume":"283","author":"Zhao","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2022.153982_bib55","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.2119\/molmed.2010.00225","article-title":"let-7 microRNAs induce tamoxifen sensitivity by downregulation of estrogen receptor \u03b1 signaling in breast cancer","volume":"17","author":"Zhao","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.prp.2022.153982_bib56","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/abbs\/gms026","article-title":"miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A","volume":"44","author":"Zhu","year":"2012","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.prp.2022.153982_bib57","first-page":"2210","article-title":"Exosome mediated multidrug resistance in cancer","volume":"8","author":"Yousafzai","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.prp.2022.153982_bib58","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1172\/JCI81135","article-title":"The biology and function of exosomes in cancer","volume":"126","author":"Kalluri","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.prp.2022.153982_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577347","article-title":"The emerging role of lncRNAs in multiple sclerosis","volume":"347","author":"Ghaderian","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.prp.2022.153982_bib60","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1159\/000495281","article-title":"Tumor-secreted exosomal miR-222 promotes tumor progression via regulating P27 expression and re-localization in pancreatic cancer","volume":"51","author":"Li","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.prp.2022.153982_bib61","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.3390\/ijms20184332","article-title":"The role of exosomes in pancreatic cancer","volume":"20","author":"Lan","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2022.153982_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms11150","article-title":"Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1","volume":"7","author":"Yeung","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2022.153982_bib63","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/onc.2016.353","article-title":"Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells","volume":"36","author":"Richards","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2022.153982_bib64","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.amjsurg.2017.03.049","article-title":"MicroRNA-21 as a prognostic biomarker in patients with pancreatic cancer\u2013a systematic review and meta-analysis","volume":"214","author":"Negoi","year":"2017","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.prp.2022.153982_bib65","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.omtn.2017.12.002","article-title":"Downregulation of MicroRNA-455-3p links to proliferation and drug resistance of pancreatic cancer cells via targeting TAZ","volume":"10","author":"Zhan","year":"2018","journal-title":"Mol. Ther. -Nucleic Acids"},{"key":"10.1016\/j.prp.2022.153982_bib66","first-page":"1","article-title":"MicroRNA-320a promotes 5-FU resistance in human pancreatic cancer cells","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2022.153982_bib67","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1159\/000503225","article-title":"MicroRNA-296-5p promotes cell invasion and drug resistance by targeting Bcl2-related ovarian killer, leading to a poor prognosis in pancreatic cancer","volume":"101","author":"Okazaki","year":"2020","journal-title":"Digestion"},{"key":"10.1016\/j.prp.2022.153982_bib68","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/bjc.2014.454","article-title":"MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer","volume":"111","author":"Hasegawa","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2022.153982_bib69","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.pan.2013.06.007","article-title":"Involvement of microRNA-181b in the gemcitabine resistance of pancreatic cancer cells","volume":"13","author":"Takiuchi","year":"2013","journal-title":"Pancreatology"},{"key":"10.1016\/j.prp.2022.153982_bib70","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.biocel.2019.01.020","article-title":"MicroRNA-137 inhibits autophagy and chemosensitizes pancreatic cancer cells by targeting ATG5","volume":"111","author":"Wang","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.prp.2022.153982_bib71","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.canlet.2016.01.038","article-title":"MicroRNA-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer","volume":"373","author":"Fan","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2022.153982_bib72","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3390\/biom11050639","article-title":"Improving gemcitabine sensitivity in pancreatic cancer cells by restoring miRNA-217 levels","volume":"11","author":"Panebianco","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.prp.2022.153982_bib73","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.canlet.2016.11.035","article-title":"microRNA-210 overexpression inhibits tumor growth and potentially reverses gemcitabine resistance in pancreatic cancer","volume":"388","author":"Amponsah","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2022.153982_bib74","first-page":"5048","article-title":"MicroRNA-429 sensitizes pancreatic cancer cells to gemcitabine through regulation of PDCD4","volume":"9","author":"Yu","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.prp.2022.153982_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep42339","article-title":"MicroRNA-155 controls exosome synthesis and promotes gemcitabine resistance in pancreatic ductal adenocarcinoma","volume":"7","author":"Mikamori","year":"2017","journal-title":"Sci. Rep."},{"issue":"39","key":"10.1016\/j.prp.2022.153982_bib76","article-title":"MiR-760 enhances sensitivity of pancreatic cancer cells to gemcitabine through modulating Integrin \u03b21","author":"Yang","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.prp.2022.153982_bib77","series-title":"A novel small nucleolar RNA\u2010derived microRNA\u20101291 targets multidrug resistance\u2010associated protein 1 (MRP1\/ABCC1)","author":"Pan","year":"2011"},{"key":"10.1016\/j.prp.2022.153982_bib78","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2782101","article-title":"MicroRNA-7 as a potential biomarker for prognosis in pancreatic cancer","volume":"2020","author":"Ye","year":"2020","journal-title":"Dis. Markers"},{"key":"10.1016\/j.prp.2022.153982_bib79","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nrc3166","article-title":"MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy","volume":"11","author":"Kasinski","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2022.153982_bib80","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/cr.2008.24","article-title":"MicroRNA-21 targets tumor suppressor genes in invasion and metastasis","volume":"18","author":"Zhu","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.prp.2022.153982_bib81","doi-asserted-by":"crossref","first-page":"8164","DOI":"10.1158\/0008-5472.CAN-08-1305","article-title":"MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells","volume":"68","author":"Papagiannakopoulos","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2022.153982_bib82","first-page":"1473","article-title":"Chemosensitivity induced by down-regulation of microRNA-21 in gemcitabine-resistant pancreatic cancer cells by indole-3-carbinol","volume":"33","author":"Paik","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.prp.2022.153982_bib83","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3727\/096504017X14934840662335","article-title":"Micro-RNA-21 regulates cancer-associated fibroblast-mediated drug resistance in pancreatic cancer","volume":"26","author":"Zhang","year":"2018","journal-title":"Oncol. Res."},{"key":"10.1016\/j.prp.2022.153982_bib84","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.prp.2022.153982_bib85","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1172\/JCI81187","article-title":"TIGIT predominantly regulates the immune response via regulatory T cells","volume":"125","author":"Kurtulus","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.prp.2022.153982_bib86","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.7150\/jca.39044","article-title":"MicroRNA-183 in cancer progression","volume":"11","author":"Cao","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.prp.2022.153982_bib87","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jss.2012.02.027","article-title":"Protective effect of dexmedetomidine in a rat model of \u03b1-naphthylthiourea\u2013induced acute lung injury","volume":"178","author":"Hanc\u0131","year":"2012","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.prp.2022.153982_bib88","first-page":"1697","article-title":"Downregulation of miR\u2011183 inhibits the growth of PANC\u20111 pancreatic cancer cells in vitro and in vivo, and increases chemosensitivity to 5\u2013fluorouracil and gemcitabine","volume":"17","author":"Yang","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.prp.2022.153982_bib89","doi-asserted-by":"crossref","first-page":"6864","DOI":"10.1111\/jcmm.16695","article-title":"Up-regulation of KISS1 as a novel target of Let-7i in melanoma serves as a potential suppressor of migration and proliferation in vitro","volume":"25","author":"Alkafaji","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.prp.2022.153982_bib90","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/14728222.2018.1535594","article-title":"Let-7 microRNA as a potential therapeutic target with implications for immunotherapy","volume":"22","author":"Gilles","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.prp.2022.153982_bib91","doi-asserted-by":"crossref","DOI":"10.21037\/sci.2017.01.01","article-title":"microRNA regulation of human pancreatic cancer stem cells","volume":"4","author":"Xu","year":"2017","journal-title":"Stem Cell Investig."},{"key":"10.1016\/j.prp.2022.153982_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053436","article-title":"Differential processing of let-7 a precursors influences RRM2 expression and chemosensitivity in pancreatic cancer: role of LIN-28 and SET oncoprotein","volume":"8","author":"Bhutia","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2022.153982_bib93","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1159\/000481610","article-title":"CXCR4\/Let-7a axis regulates metastasis and chemoresistance of pancreatic cancer cells through targeting HMGA2","volume":"43","author":"Xiao","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.prp.2022.153982_bib94","volume":"10","author":"Iacona","year":"2019"},{"key":"10.1016\/j.prp.2022.153982_bib95","doi-asserted-by":"crossref","first-page":"9495","DOI":"10.1002\/jcb.28225","article-title":"Downregulation of miR-146a promotes cell migration in Helicobacter pylori-negative gastric cancer","volume":"120","author":"Shomali","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.prp.2022.153982_bib96","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.biopha.2017.09.138","article-title":"MiR-146a functions as a small silent player in gastric cancer","volume":"96","author":"Shomali","year":"2017","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2022.153982_bib97","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.canlet.2018.04.028","article-title":"miRNA 146a promotes chemotherapy resistance in lung cancer cells by targeting DNA damage inducible transcript 3 (CHOP)","volume":"428","author":"Tan","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2022.153982_bib98","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.7150\/thno.40566","article-title":"A miR-146a-5p\/TRAF6\/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance","volume":"10","author":"Meng","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.prp.2022.153982_bib99","article-title":"HSP90 inhibitor modulates HMGA1 and HMGB2 expression along with cell viability via NF-KB signaling pathways in melanoma in-vitro","volume":"24","author":"Shomali","year":"2021","journal-title":"Gene Rep."},{"key":"10.1016\/j.prp.2022.153982_bib100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2011.09.038","article-title":"ABCB1\/MDR1 contributes to the anticancer drug-resistant phenotype of IPH-926 human lobular breast cancer cells","volume":"315","author":"Krech","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2022.153982_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2017.05.007","article-title":"Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205","volume":"402","author":"Chaudhary","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2022.153982_bib102","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1038\/onc.2009.158","article-title":"Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma","volume":"28","author":"Akita","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2022.153982_bib103","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/ijc.22390","article-title":"Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer","volume":"120","author":"Nakahira","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2022.153982_bib104","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.18632\/oncotarget.2946","article-title":"\u03b2III-tubulin: a novel mediator of chemoresistance and metastases in pancreatic cancer","volume":"6","author":"McCarroll","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2022.153982_bib105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106343","article-title":"A miRNA signature of chemoresistant mesenchymal phenotype identifies novel molecular targets associated with advanced pancreatic cancer","volume":"9","author":"Bera","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2022.153982_bib106","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/gcc.22698","article-title":"miR\u2010155 expression in antitumor immunity: the higher the better?","volume":"58","author":"Michaille","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.prp.2022.153982_bib107","doi-asserted-by":"crossref","first-page":"45547","DOI":"10.18632\/oncotarget.9999","article-title":"MicroRNA-1291 targets the FOXA2-AGR2 pathway to suppress pancreatic cancer cell proliferation and tumorigenesis","volume":"7","author":"Tu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2022.153982_bib108","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/biomedicines9030325","article-title":"MiR-7 in cancer development","volume":"9","author":"Kora\u0107","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.prp.2022.153982_bib109","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.biocel.2014.05.040","article-title":"microRNA-7: a tumor suppressor miRNA with therapeutic potential","volume":"54","author":"Kalinowski","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.prp.2022.153982_bib110","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrm2868","article-title":"MicroRNA control of signal transduction","volume":"11","author":"Inui","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.prp.2022.153982_bib111","doi-asserted-by":"crossref","first-page":"7697","DOI":"10.3390\/ijms21207697","article-title":"The Wnt signalling pathway: a tailored target in cancer","volume":"21","author":"Koni","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2022.153982_bib112","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1038\/onc.2009.80","article-title":"The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt\/\u03b2-catenin pathway","volume":"28","author":"Flahaut","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2022.153982_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-016-0541-3","article-title":"Wnt-signalling pathways and microRNAs network in carcinogenesis: experimental and bioinformatics approaches","volume":"15","author":"Onyido","year":"2016","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2022.153982_bib114","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3892\/ijo.2013.2037","article-title":"MicroRNA-29a induces resistance to gemcitabine through the Wnt\/\u03b2-catenin signaling pathway in pancreatic cancer cells","volume":"43","author":"Nagano","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.prp.2022.153982_bib115","doi-asserted-by":"crossref","DOI":"10.1177\/1533033820945801","article-title":"MiR-331-3p links to drug resistance of pancreatic cancer cells by activating WNT\/\u03b2-catenin signal via ST7L","volume":"19","author":"Zhan","year":"2020","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.prp.2022.153982_bib116","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nm.3914","article-title":"The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.prp.2022.153982_bib117","first-page":"173","article-title":"Role of Notch signaling pathway in pancreatic cancer","volume":"7","author":"Gao","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.prp.2022.153982_bib118","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/jcp.25206","article-title":"Involvement of Notch\u20101 in resistance to regorafenib in colon cancer cells","volume":"231","author":"Mirone","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.prp.2022.153982_bib119","first-page":"3415","article-title":"Notch signaling and non-small cell lung cancer","volume":"15","author":"Zou","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2022.153982_bib120","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.3390\/cells9102204","article-title":"Notch signaling in breast cancer: a role in drug resistance","volume":"9","author":"BeLow","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.prp.2022.153982_bib121","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/jcb.22451","article-title":"Down\u2010regulation of Notch\u20101 and Jagged\u20101 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF\u2010\u03baB signaling pathways","volume":"109","author":"Wang","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.prp.2022.153982_bib122","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bbrc.2019.01.030","article-title":"Leptin-elicited miRNA-342-3p potentiates gemcitabine resistance in pancreatic ductal adenocarcinoma","volume":"509","author":"Ma","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2022.153982_bib123","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","article-title":"PI3K\/Akt signalling pathway and cancer","volume":"30","author":"Vara","year":"2004","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.prp.2022.153982_bib124","first-page":"1439","article-title":"MicroRNAs and the PTEN\/PI3K\/Akt pathway in gastric cancer","volume":"41","author":"Hu","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2022.153982_bib125","first-page":"7696","article-title":"Increased miR-142 and decreased DJ-1 enhance the sensitivity of pancreatic cancer cell to adriamycin","volume":"22","author":"Han","year":"2018","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"10.1016\/j.prp.2022.153982_bib126","first-page":"8833","article-title":"MiR-203 regulates DJ-1 expression and affects proliferation, apoptosis and DDP resistance of pancreatic cancer cells","volume":"23","author":"Du","year":"2019","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"10.1016\/j.prp.2022.153982_bib127","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/cells9010217","article-title":"Role of JAK\/STAT3 signaling in the regulation of metastasis, the transition of cancer stem cells, and chemoresistance of cancer by epithelial\u2013mesenchymal transition","volume":"9","author":"Jin","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.prp.2022.153982_bib128","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/s13104-020-05427-1","article-title":"Epigenetic mechanisms shape the underlining expression regulatory mechanisms of the STAT3 in multiple sclerosis disease","volume":"13","author":"Hosseini","year":"2020","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.prp.2022.153982_bib129","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1158\/0008-5472.CAN-11-0908","article-title":"STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis","volume":"71","author":"Corcoran","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2022.153982_bib130","doi-asserted-by":"crossref","first-page":"11708","DOI":"10.18632\/oncotarget.7336","article-title":"Overcoming chemo\/radio-resistance of pancreatic cancer by inhibiting STAT3 signaling","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2022.153982_bib131","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1200\/jco.2012.30.4_suppl.181","article-title":"Relationship of STAT3-mediated treatment resistance on activated MAPK signaling in pancreatic cancer","volume":"30","author":"Nagathihalli","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2022.153982_bib132","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.omtn.2018.01.004","article-title":"miR-1266 contributes to pancreatic cancer progression and chemoresistance by the STAT3 and NF-\u03baB signaling pathways","volume":"11","author":"Zhang","year":"2018","journal-title":"Mol. Ther. -Nucleic Acids"},{"key":"10.1016\/j.prp.2022.153982_bib133","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092459","article-title":"STAT3, the challenge for chemotherapeutic and radiotherapeutic efficacy","volume":"12","author":"Yang","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2022.153982_bib134","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/CM9.0000000000001826","article-title":"MicroRNAs as potential therapeutic targets for pancreatic cancer","volume":"135","author":"Chu","year":"2021","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.prp.2022.153982_bib135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-3-319-23730-5_5","article-title":"Insights into the role of microRNAs in Pancreatic cancer pathogenesis: potential for diagnosis, prognosis, and therapy","volume":"889","author":"Khan","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.prp.2022.153982_bib136","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/carcin\/bgz121","article-title":"MicroRNA-301a promotes pancreatic cancer invasion and metastasis through the JAK\/STAT3 signaling pathway by targeting SOCS5","volume":"41","author":"Hu","year":"2020","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.prp.2022.153982_bib137","first-page":"6906","article-title":"MiR-203 regulates JAK-STAT pathway in affecting pancreatic cancer cells proliferation and apoptosis by targeting SOCS3","volume":"23","author":"Lin","year":"2019","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"10.1016\/j.prp.2022.153982_bib138","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.canlet.2014.01.020","article-title":"MicroRNA let-7 downregulates STAT3 phosphorylation in pancreatic cancer cells by increasing SOCS3 expression","volume":"347","author":"Patel","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2022.153982_bib139","doi-asserted-by":"crossref","first-page":"11708","DOI":"10.18632\/oncotarget.7336","article-title":"Overcoming chemo\/radio-resistance of pancreatic cancer by inhibiting STAT3 signaling","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2022.153982_bib140","first-page":"115","article-title":"STAT3 as an emerging molecular target in pancreatic cancer","volume":"4","author":"Sharma","year":"2014","journal-title":"Gastrointest. Cancer: Targets Ther."},{"key":"10.1016\/j.prp.2022.153982_bib141","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.gde.2008.01.020","article-title":"NF-\u03baB and cancer\u2014identifying targets and mechanisms","volume":"18","author":"Naugler","year":"2008","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.prp.2022.153982_bib142","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0014-4827(03)00223-4","article-title":"Inhibition of inducible NF-\u03baB activity reduces chemoresistance to 5-fluorouracil in human stomach cancer cell line","volume":"289","author":"Uetsuka","year":"2003","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.prp.2022.153982_bib143","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.3390\/ijms19123890","article-title":"Advancement of NF-\u03baB signaling pathway: a novel target in pancreatic cancer","volume":"19","author":"Pramanik","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2022.153982_bib144","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1038\/onc.2012.179","article-title":"The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the concentrative nucleoside transporter family","volume":"32","author":"Skrypek","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2022.153982_bib145","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.7150\/thno.40566","article-title":"A miR-146a-5p\/TRAF6\/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance","volume":"10","author":"Meng","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.prp.2022.153982_bib146","first-page":"1886","article-title":"Downregulation of miR-301a-3p sensitizes pancreatic cancer cells to gemcitabine treatment via PTEN","volume":"9","author":"Xia","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.prp.2022.153982_bib147","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.omtn.2018.01.004","article-title":"miR-1266 contributes to pancreatic cancer progression and chemoresistance by the STAT3 and NF-\u03baB signaling pathways","volume":"11","author":"Zhang","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.prp.2022.153982_bib148","first-page":"1","article-title":"The roles of microRNA in pancreatic cancer progression","author":"Ramya Devi","year":"2022","journal-title":"Cancer Investig."},{"key":"10.1016\/j.prp.2022.153982_bib149","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fgene.2012.00120","article-title":"miR-34\u2013a microRNA replacement therapy is headed to the clinic","volume":"3","author":"Bader","year":"2012","journal-title":"Front. Genet."},{"key":"10.1016\/j.prp.2022.153982_bib150","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s10038-021-00938-6","article-title":"Cancer-associated miRNAs and their therapeutic potential","volume":"66","author":"Inoue","year":"2021","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.prp.2022.153982_bib151","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2174\/13894501113149990181","article-title":"Prospects of miRNA-based therapy for pancreatic cancer","volume":"14","author":"Pai","year":"2013","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.prp.2022.153982_bib152","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1101\/gad.1950610","article-title":"Repression of the miR-143\/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway","volume":"24","author":"Kent","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.prp.2022.153982_bib153","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.1007\/s13277-014-1784-5","article-title":"Quantitative metabolome analysis profiles activation of glutaminolysis in glioma with IDH1 mutation","volume":"35","author":"Ohka","year":"2014","journal-title":"Tumor Biol."},{"key":"10.1016\/j.prp.2022.153982_bib154","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/carcin\/bgr223","article-title":"MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells","volume":"32","author":"Srivastava","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.prp.2022.153982_bib155","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41388-019-0966-4","article-title":"BMI1 is directly regulated by androgen receptor to promote castration-resistance in prostate cancer","volume":"39","author":"Zhu","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2022.153982_bib156","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkp211","article-title":"Accurate characterization of weak macromolecular interactions by titration of NMR residual dipolar couplings: application to the CD2AP SH3-C: ubiquitin complex","volume":"37","author":"Ortega-Roldan","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.prp.2022.153982_bib157","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1261\/rna.1952110","article-title":"Molecular mechanisms that funnel RNA precursors into endogenous small-interfering RNA and microRNA biogenesis pathways in Drosophila","volume":"16","author":"Miyoshi","year":"2010","journal-title":"Rna"},{"key":"10.1016\/j.prp.2022.153982_bib158","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O\u2019Brien","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.prp.2022.153982_bib159","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ymeth.2007.11.001","article-title":"Inhibition of microRNA with antisense oligonucleotides","volume":"44","author":"Esau","year":"2008","journal-title":"Methods"},{"key":"10.1016\/j.prp.2022.153982_bib160","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","article-title":"Noncoding RNA therapeutics\u2014Challenges and potential solutions","volume":"20","author":"Winkle","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.prp.2022.153982_bib161","doi-asserted-by":"crossref","first-page":"7592","DOI":"10.1002\/ange.200801555","article-title":"Small\u2010molecule inhibitors of microrna miR\u201021 function","volume":"120","author":"Gumireddy","year":"2008","journal-title":"Angew. Chem."},{"key":"10.1016\/j.prp.2022.153982_bib162","doi-asserted-by":"crossref","first-page":"7976","DOI":"10.1021\/ja910275u","article-title":"Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma","volume":"132","author":"Young","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.prp.2022.153982_bib163","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1097\/MPA.0b013e3181ba82e1","article-title":"Antisense inhibition of microRNA-21 or-221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma","volume":"38","author":"Park","year":"2009","journal-title":"Pancreas"},{"key":"10.1016\/j.prp.2022.153982_bib164","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1053\/j.gastro.2009.08.065","article-title":"Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer","volume":"137","author":"Weiss","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prp.2022.153982_bib165","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbrc.2011.02.065","article-title":"miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor","volume":"406","author":"Park","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2022.153982_bib166","first-page":"3203","article-title":"MicroRNA modulation combined with sunitinib as a novel therapeutic strategy for pancreatic cancer","volume":"9","author":"Passadouro","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.prp.2022.153982_bib167","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.addr.2014.10.020","article-title":"Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer","volume":"81","author":"Rachagani","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.prp.2022.153982_bib168","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature16064","article-title":"Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer","volume":"527","author":"Zheng","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.prp.2022.153982_bib169","doi-asserted-by":"crossref","first-page":"314","DOI":"10.5114\/ceji.2018.80051","article-title":"MicroRNAs in pancreatic cancer diagnosis and therapy","volume":"43","author":"S\u0142otwi\u0144ski","year":"2018","journal-title":"Cent. -Eur. J. Immunol."},{"key":"10.1016\/j.prp.2022.153982_bib170","first-page":"414","article-title":"MicroRNAs in cancer treatment and prognosis","volume":"2","author":"Schoof","year":"2012","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.prp.2022.153982_bib171","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101322","article-title":"The role of microRNA in pancreatic cancer","volume":"9","author":"Smolarz","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.prp.2022.153982_bib172","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.3748\/wjg.v20.i9.2335","article-title":"Hedgehog signaling pathway as a new therapeutic target in pancreatic cancer","volume":"20","author":"Onishi","year":"2014","journal-title":"World J. Gastroenterol.: WJG"},{"key":"10.1016\/j.prp.2022.153982_bib173","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3390\/ijms17050718","article-title":"Managing pancreatic adenocarcinoma: a special focus in microRNA gene therapy","volume":"17","author":"Passadouro","year":"2016","journal-title":"Int. J. Mol. Sci."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822002266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822002266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:54:27Z","timestamp":1759733667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033822002266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":173,"alternative-id":["S0344033822002266"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2022.153982","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between microRNAs and chemoresistance in pancreatic cancer: Current knowledge, new insights, and forthcoming perspectives","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2022.153982","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"153982"}}